Having trouble accessing articles? Reset your cache.

Amgen's balance sheet shuffle

Amgen's balance sheet shuffle

Last week, Amgen (AMGN) sold $4 billion in notes, saying it plans to use $3 billion of the proceeds to buy back shares.

Read the full 261 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE